retatrutide peptide bodybuilding — Fat Loss Breakthrough or Overhyped? Retatrutide is a next-gen injectable that works as a triple agonist — hitting GLP-1, GIP, and glucagon receptors all at once. That means: ✓ Buy Retatrutide (Reta) UK 10mg

Tirzepatide has been around for a few years

Most GLP-1 medications are taken via injection daily or weekly

The STEP 2 trial, conducted in patients with type 2 diabetes, demonstrated even greater triglyceride reductions (averaging 20-25%), likely reflecting the baseline metabolic dysfunction in this population

GIP agonism: Activates GIP receptors, improves insulin secretion efficiency, promotes fat metabolism, reduces fat accumulation, and enhances bone health

Latin America held a 3% share of the market in 2025 and is expected to grow at a significant CAGR of 14% during the projection period, driven by GLP-1 medications that are driving structural health and economic shifts across Latin America by curbing surging obesity and type-2 diabetes rates, spurring vast biopharma investments, and fundamentally changing consumer habits in the fast-moving consumer goods sector

Wegovy has shown promise in improving MASH. If confirmed in larger trials, GLP1 drugs could become a cornerstone of liver disease management